Mechanisms of cancer cell metastasis to the bone: a multistep process.
暂无分享,去创建一个
Kenneth J Pienta | K. Pienta | Y. Shiozawa | R. Taichman | Lalit R. Patel | Yusuke Shiozawa | Lalit R Patel | Daniel F Camacho | Russell S Taichman | D. F. Camacho
[1] James Ewing,et al. Neoplastic Diseases: A Treatise on Tumours , 1928, The Indian Medical Gazette.
[2] R. Rubens,et al. The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.
[3] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[4] B. Zetter,et al. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. , 1990, Biochimica et biophysica acta.
[5] G. Miller,et al. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. , 1994, The Journal of urology.
[6] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[7] Michael Kühl,et al. Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.
[8] B. Zetter,et al. Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.
[9] N. Maitland,et al. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.
[10] L. Chung,et al. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment , 1999, The Prostate.
[11] M. Pepper,et al. Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] Jian Zhang,et al. Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro , 2001, The Prostate.
[13] R. Coleman. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. , 2001, Cancer treatment reviews.
[14] Evan T Keller,et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.
[15] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[16] S. Teitelbaum,et al. Genetic regulation of osteoclast development and function , 2003, Nature Reviews Genetics.
[17] R. Salcedo,et al. Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses , 2003, Microcirculation.
[18] S. Varambally,et al. JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.
[19] G. Roodman. Mechanisms of bone metastasis. , 2004, Discovery medicine.
[20] P. Codogno,et al. Autophagy and signaling: their role in cell survival and cell death , 2005, Cell Death and Differentiation.
[21] Christie M. Orschell,et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.
[22] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[23] C. Logothetis,et al. Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.
[24] K. Pienta,et al. The "emigration, migration, and immigration"of prostate cancer. , 2005, Clinical prostate cancer.
[25] S. Chiba. Concise Review: Notch Signaling in Stem Cell Systems , 2006 .
[26] J. Aguirre-Ghiso,et al. Tumor cell dormancy induced by p38SAPK and ER-stress signaling: An adaptive advantage for metastatic cells? , 2006, Cancer biology & therapy.
[27] L. Akslen,et al. Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.
[28] P. Rameshwar,et al. SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. , 2006, Blood.
[29] Ralph S. Da Costa,et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. , 2007, Journal of the National Cancer Institute.
[30] R. Vessella,et al. Tumor cell dormancy: An NCI workshop report , 2007, Cancer biology & therapy.
[31] J. Massagué,et al. Genetic determinants of cancer metastasis , 2007, Nature Reviews Genetics.
[32] H. Yamaguchi,et al. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. , 2007, Cancer research.
[33] B. Trask,et al. Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. , 2008, Cancer research.
[34] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[35] K. Pienta,et al. Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer , 2008, Journal of cellular biochemistry.
[36] K. Pienta,et al. CCL2, survivin and autophagy: New links with implications in human cancer , 2008, Autophagy.
[37] R. Vessella,et al. Cancer micrometastasis and tumour dormancy , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[38] Gerhard Christofori,et al. EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.
[39] K. Pienta,et al. The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer* , 2008, Journal of Biological Chemistry.
[40] P. Allavena,et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.
[41] D. Rodenhiser,et al. Epigenetic contributions to cancer metastasis , 2008, Clinical and Experimental Metastasis.
[42] C. Horak,et al. The role of metastasis suppressor genes in metastatic dormancy , 2008 .
[43] L. Hartmann,et al. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligands , 2008, International journal of cancer.
[44] Bart Barlogie,et al. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling. , 2008, Blood.
[45] K. Pienta,et al. Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts , 2009, Journal of cellular biochemistry.
[46] W. Ellis,et al. Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence , 2009, Clinical Cancer Research.
[47] V. Kuchroo,et al. Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.
[48] Jun Luo,et al. Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.
[49] P. Carroll,et al. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy , 2009, Cancer.
[50] K. Pienta,et al. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.
[51] Henrik Toft Sørensen,et al. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). , 2010, The Journal of urology.
[52] Yuehua Wu,et al. The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction , 2010, Cancer biology & therapy.
[53] K. Pienta,et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.
[54] Gerald C. Chu,et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression , 2011, Nature.
[55] J. Schneider,et al. Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. , 2011, Bone.
[56] Yibin Kang,et al. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.
[57] T. Fehm,et al. Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis , 2011, Clinical Cancer Research.
[58] J. Cheng,et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.
[59] Steven J. Greco,et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.